Integra LifeSciences Holdings (IART) remains unprofitable, with losses accelerating at a 59% per year pace over the last five years. Revenue is forecast to grow just 2.5% annually, trailing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback